ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL
|
Back to Search Results |
|
Model Number 23VAVGJ-515 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Hematoma (1884); Pleural Effusion (2010); Pulmonary Edema (2020); Thrombosis/Thrombus (4440)
|
Event Date 01/31/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
Crd_992 - valved grafts pas pl5012-195 r739423601.It was reported that on (b)(6) 2023, a 23mm masters mechanical heart valve was selected for an implant.While transporting the patient to the operating room to connect the patient to extracorporeal membrane oxygenation (ecmo), a pulmonary edema was noted before connecting.On (b)(6) 2023, after evaluation of laboratory tests, gasometry, chest x-ray, and left pleural puncture with evacuation of 200ml of blood fluid, the ecmo cannulas were removed.On (b)(6) 2023, chest computed tomography (ct) was performed which showed fluid and clots in the left pleural cavity.Thoracotomy was performed and 1700 ml of clots and fluid were evacuated.Hematoma of the left pleural cavity was also observed, but the site of bleeding was not visualized.The inr on (b)(6) 2023 was 3.4; inr on (b)(6) 2023 was 1.4.On (b)(6) 2023, inr was 1.27.The patient did not have any hematologic disorders or systemic illness that could contribute to a hypercoagulability.The patient was reported to be in stable condition.
|
|
Event Description
|
Crd_992 - valved grafts pas pl5012-195 r739423601 it was reported that on (b)(6) 2023, a 23mm masters mechanical heart valve was selected for an implant.While transporting the patient to the operating room to connect the patient to extracorporeal membrane oxygenation (ecmo), a pulmonary edema was noted before connecting.On (b)(6) 2023, after evaluation of laboratory tests, gasometry, chest x-ray, and left pleural puncture with evacuation of 200ml of blood fluid, the ecmo cannulas were removed.Device was successfully implanted.On (b)(6) 2023, chest computed tomography (ct) was performed which showed fluid and clots in the left pleural cavity.Thoracotomy was performed and 1700 ml of clots and fluid were evacuated.Hematoma of the left pleural cavity was also observed, but the site of bleeding was not visualized.The inr on (b)(6) 2023 was 3.4; inr on (b)(6) 2023 was 1.4.On 26 february 2023, inr was 1.27.The patient did not have any hematologic disorders or systemic illness that could contribute to a hypercoagulability.The patient was reported to be in stable condition.
|
|
Manufacturer Narrative
|
An event of bleeding, pericardial effusion, pulmonary edema and thrombus was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Field beleived that the patient did not have any hematologic disorders or systemic illness that could contribute to a hypercoagulability.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met specifications.H6 medical device problem code: code 4001 was removed.
|
|
Search Alerts/Recalls
|
|
|